SRP-9001 for treating patients with Duchenne muscular dystrophy Presented ByDr Jerry Mendell, Nationwide Children's Hospital, OH, USA ConferenceAAN 2022 2 June, 2022 16:17
Novel AAV-based gene therapy for Duchenne muscular dystrophy TrialPhase 2, SRP-9001-102 ConferenceAAN 2021 16 June, 2021 11:38
Ataluren in nonsense mutation Duchenne TrialCohort study, STRIDE, CINRG ConferenceEAN 2019 27 August, 2019 19:44